Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2000, p. 2688-2695, Vol. 38, No. 7
Division of Human Biology, Fred Hutchinson
Cancer Research Center,1 and Departments
of Biostatistics,4
Medicine,2 and
Epidemiology,9 University of Washington,
Seattle, Washington; Gen-Probe Incorporated, San Diego,
California3; Henry M. Jackson
Foundation,5 and Division of
Retrovirology, Walter Reed Army Institute of
Research,6 Rockville, Maryland; and
Departments of Pediatrics7 and
Medical Microbiology,8 University of
Nairobi, Nairobi, Kenya
Received 11 November 1999/Returned for modification 13 March
2000/Accepted 24 April 2000
Accurate and sensitive quantification of human immunodeficiency
virus type 1 (HIV-1) RNA has been invaluable as a marker for disease
prognosis and for clinical monitoring of HIV-1 disease. The first
generation of commercially available HIV-1 RNA tests were optimized to
detect the predominant HIV-1 subtype found in North America and Europe,
subtype B. However, these tests are frequently suboptimal in detecting
HIV-1 genetic forms or subtypes found in other parts of the world. The
goal of the present study was to evaluate the performance of a new
viral load assay with non-subtype B viruses. A transcription-mediated
amplification method for detection and quantitation of diverse HIV-1
subtypes, called the Gen-Probe HIV-1 viral load assay, is under
development. In this study we examined the performance of the Gen-Probe
HIV-1 viral load assay relative to that of the commonly used commercial HIV-1 RNA assays using a panel of primary isolates from Kenya. For
comparison, we included several subtype B cloned viruses, and we
quantified each virus using an in-house quantitative-competitive reverse transcriptase PCR (QC-RT-PCR) method and gagp24
antigen capture. The Gen-Probe HIV-1 viral load assay and a version of
the Roche AMPLICOR HIV-1 MONITOR test (version 1.5) that was designed
to detect a broader range of subtypes were both sensitive for the
quantification of Kenyan primary isolates, which represented subtype A,
C, and D viruses. The Gen-Probe HIV-1 viral load assay was more
sensitive for the majority of viruses than the Roche AMPLICOR HIV-1
MONITOR test version 1.0, the Bayer Quantiplex HIV RNA 3.0 assay, or a
QC-RT-PCR method in use in our laboratory, suggesting that it provides
a useful method for quantifying HIV-1 RNAs from diverse parts of the
world, including Africa.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of Performance of the Gen-Probe Human Immunodeficiency
Virus Type 1 Viral Load Assay Using Primary Subtype A, C, and D
Isolates from Kenya
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave. N., C3-168, Seattle, WA 98109. Phone: (206) 667-3524. Fax: (206) 667-1535. E-mail:
joverbau{at}fhcrc.org.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»